Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

LAMA2-related myopathy; frequency among congenital and limb-girdle muscular dystrophies

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Molecular indicators of denervation in aging human skeletal muscle

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Moderate-intensity aerobic exercise improves physical fitness in bethlem myopathy

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Long-term safety and efficacy of eculizumab in generalized myasthenia gravis

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Impaired lipolysis in propionic acidemia: A new metabolic myopathy?

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Increased risk of sudden death in untreated Primary Carnitine Deficiency

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Cystic fibrosis newborn screening in Denmark: Experience from the first 2 years

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Absence of p.R50X Pygm read-through in McArdle disease cellular models

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

Introduction: Muscular dystrophy caused by LAMA2-gene mutations is an autosomal recessive disease typically presenting as a severe, early-onset congenital muscular dystrophy (CMD). However, milder cases with a limb-girdle type muscular dystrophy (LGMD) have been described. Methods: In this study, we assessed the frequency and phenotypic spectrum of LAMA2-related muscular dystrophy in cohorts of CMD (n=18) and LGMD2 (n=128) identified in the last 15 years in eastern Denmark. The medical history, brain-MRI, muscle pathology, muscle laminin-α2 expression, and genetic analyses were assessed. Results: Molecular genetics revealed 2 pathogenic LAMA2 mutations in 5/18 CMD and 3/128 LGMD patients, corresponding to a LAMA2-mutation frequency of 28% in the CMD and 2.3% in the LGMD cohorts, respectively. Discussion: This study demonstrates a wide clinical spectrum of LAMA2-related muscular dystrophy and its prevalence in an LGMD2 cohort, which indicates that LAMA2 muscular dystrophy should be included in the LGMD2 nomenclature. This article is protected by copyright. All rights reserved.

Original languageEnglish
JournalMuscle & Nerve
Pages (from-to)547-553
ISSN0148-639X
DOIs
Publication statusPublished - 5 Feb 2015

ID: 45042379